Description: AtriCure, Inc., a medical device company, develops, manufactures, and sells cardiac surgical ablation systems designed to create precise lesions or scars in cardiac tissue. It provides isolator bipolar radio-frequency ablation clamps that are used for ablation during open-heart procedures; and ablation and sensing unit, a compact power generator that provides the radio-frequency (RF) energy for its clamps, multifunctional pens, and coolrail linear ablation devices. The company also offers AtriCure switch box, a compact switch box, which offers the technology needed for the dual pulsing electrodes in isolator synergy clamps; isolator multifunctional pens that enable surgeons to evaluate cardiac arrhythmias, as well as to perform temporary cardiac pacing, sensing, and stimulation and ablate cardiac tissue with the same device; and coolrail linear ablation device, a disposable linear RF ablation device that allows physicians to create an expanded cardiac ablation lesion set during minimally invasive procedures. In addition, it provides cryoablation system, which is used for AF ablation treatment during certain open-heart procedures; and AtriClip System that is designed to exclude the left atrial appendage by implanting the device during concomitant open surgical procedures. Further, the company sells technologies, including Lumitip dissector to separate tissues to provide access to anatomical structures that are targeted for ablation; and the MicroPace ORLab system, a stimulating, mapping, and recording system, which enables physicians to confirm that the ablation lines being created are forming electrical barriers or lines of block. The company sells its products to hospitals and medical centers through independent distributors and direct sales personnel worldwide. AtriCure, Inc. is headquartered in West Chester, Ohio.
Home Page: www.atricure.com
ATRC Technical Analysis
7555 Innovation Way
Mason,
OH
45040
United States
Phone:
513 755 4100
Officers
Name | Title |
---|---|
Mr. Michael H. Carrel | CEO, Pres & Director |
Ms. Angela L. Wirick CPA | Chief Financial Officer |
Mr. Douglas J. Seith | Chief Operating Officer |
Dr. Vinayak Doraiswamy Ph.D. | Chief Scientific Officer |
Mr. Justin J. Noznesky | Chief Marketing & Strategy Officer |
Mr. Salvatore Privitera J.D. | Chief Technical Officer |
Mr. Karl S. Dahlquist C.C.E.P., CCEP, J.D. | Chief Legal & Compliance Officer |
Valerie Storch-Willhaus | VP of Corp. Marketing & Communications |
Ms. Deborah Yount | Chief HR Officer |
Mr. Amalio Telenti M.D., Ph.D. | Exec. VP & Chief Data Officer |
Exchange: NASDAQ
Country: US
Currency: US Dollar ($)
GIC Sector: | Health Care |
---|---|
GIC Group: | Health Care Equipment & Services |
GIC Industry: | Health Care Equipment & Supplies |
GIC Sub-Industry: | Health Care Equipment |
Forward PE: | 0 |
---|---|
Trailing PE: | 39.0769 |
Price-to-Book MRQ: | 4.5361 |
Price-to-Sales TTM: | 6.2592 |
IPO Date: | 2005-08-05 |
Fiscal Year End: | December |
Full Time Employees: | 875 |